ðɪ ˈʌpwɚd tɹˈɛnd ɪn ædvˈɜːs ɹɪˈækʃən ɹᵻpˈoːɹɾɪŋ ɹˈeɪts hæd nˌɑːt bˌɪn əbzˈɜːvd wɪððə jˈuːs ʌv lˈaɪəfˌɪlaɪzd sˈɑːɹɡɹɐmˌoʊstɪm.
The upward trend in adverse reaction reporting rates had not been observed with the use of lyophilized sargramostim.